Alcohol consumption is associated with lower self-reported disease activity and better health-related quality of life in female rheumatoid arthritis patients in Sweden: data from BARFOT, a multicenter study on early RAShow others and affiliations
2013 (English)In: BMC Musculoskeletal Disorders, E-ISSN 1471-2474, Vol. 14, p. Article 218-Article in journal (Refereed) Published
Abstract [en]
BACKGROUND: Earlier studies have found a positive effect of alcohol consumption, with a reduced disease activity in rheumatoid arthritis (RA). The aim of this study was to assess alcohol consumption and its association with disease activity and health related quality of life (HRQL) in Swedish RA patients.
METHODS: Between 1992 and 2005, 2,800 adult patients were included in the BARFOT study of early RA in Sweden. In 2010 a self-completion postal questionnaire was sent to all 2,102 prevalent patients in the BARFOT study enquiring about disease severity, HRQL, and lifestyle factors. Alcohol consumption was assessed using the validated AUDIT-C questionnaire.
RESULTS: A total of 1,238 out of 1,460 patients answering the questionnaire had data on alcohol consumption: 11% were non-drinkers, 67% had a non-hazardous drinking, and 21% were classified as hazardous drinkers. Women who drank alcohol reported lower disease activity and better HRQL, but there were no association between alcohol consumption and disease activity in men. For current smokers, alcohol use was only associated with fewer patient-reported swollen joints. The outcome was not affected by kind of alcohol consumed.
CONCLUSIONS: There was an association between alcohol consumption and both lower self-reported disease activity and higher HRQL in female, but not in male, RA patients. © 2013 Bergman et al.; licensee BioMed Central Ltd.
Place, publisher, year, edition, pages
London: BioMed Central, 2013. Vol. 14, p. Article 218-
Keywords [en]
Alcohol, EULAR response criteria, Health-related quality of life, Rheumatoid arthritis
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:hh:diva-25091DOI: 10.1186/1471-2474-14-218ISI: 000322732400001PubMedID: 23879655Scopus ID: 2-s2.0-84880375940OAI: oai:DiVA.org:hh-25091DiVA, id: diva2:712829
Note
Members of the BARFOT study group: Sofia Ajeganova, Maria Andersson, Valentina Bala, Stefan Bergman, Kristina Forslind, Ingiäld Hafström, Catharina Keller, Ido Leden, Bengt Lindell, Ingemar Petersson, Christoffer Schaufelberger, Björn Svensson, Maria Söderlin, Annika Teleman, Jan Theander, and Anneli Östenson.
This study was supported by grants from the Swedish Society of Medicine, the Swedish Rheumatism Association, the Research Department of the County Council of Halland, the Gothenburg District Rheumatology Foundation, and the Crafoord Foundation.
2014-04-162014-04-162024-01-17Bibliographically approved